SCHEMBL6201213

SCHEMBL6201213

COC(O)c1cc(-c2ccccc2)on1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.50
CHRM1 P11229 1/20 0.50
DRD1 P21728 1/20 0.50
SLC6A2 P23975 1/20 0.50
ADRA1A P35348 1/20 0.50
OPRM1 P35372 1/20 0.50
DRD3 P35462 1/20 0.50
HRH3 Q9Y5N1 1/20 0.50
RAB9A P51151 6/20 0.48
NPC1 O15118 5/20 0.48
ALDH1A1 P00352 5/20 0.47
NOTUM Q6P988 1/20 0.46
F2RL1 P55085 1/20 0.45
HPGD P15428 3/20 0.44
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4050309 0.81 CHRM2 (0.54) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL18974099 0.81 CHRM2 (0.54) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL20668990 0.81 CHRM2 (0.56) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL18618112 0.78 CHRM2 (0.54) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL724985 0.78 MEN1 (0.45) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL2737273 0.78 RAB9A (0.55) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL11804742 0.75 RAB9A (0.52) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL16088990 0.75 RAB9A (0.52) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL11783617 0.74 CHRM2 (0.60) CHRM2CHRM1DRD1SLC6A2ADRA1A
SCHEMBL11804701 0.74 CHRM2 (0.56) CHRM2CHRM1DRD1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed